Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,945 | 2,030 | 11:29 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
MENTICE Aktie jetzt für 0€ handeln | |||||
14.02. | MENTICE AB: Mentice comments on strong Q4 financial performance | 2 | Cision News | ||
13.02. | Mentice AB: Mentice publishes the company's year-end report for the period January-December 2024 | 63 | GlobeNewswire (Europe) | STRONG CLOSING QUARTER
SIGNIFICANT EVENTS DURING THE FORTH QUARTER 2024 (OCT - DEC)Mentice announced the recruitment of Frans Venker as new CEO, starting Jan 1, 2025.The order intake during the quarter... ► Artikel lesen | |
03.02. | Research and Markets: Europe Surgical Robotics Simulation Market Research 2024-2033, Profiles of Fundamental Surgery, Metall-Zug, Mentice, Surgical Science Sweden, VirtaMed, VOXEL-MAN - ResearchAndMarkets.com | 289 | Business Wire | The "Europe Surgical Robotics Simulation Market: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe surgical robotics simulation market was... ► Artikel lesen | |
11.12.24 | MENTICE AB: "Mentice's solutions will become even more crucial in the future", says new CEO | 2 | Cision News | ||
28.11.24 | Mentice AB: Announcement of New CEO Appointment | 328 | GlobeNewswire (Europe) | Mentice (publ), Gothenburg, a globally recognized leader in simulation solutions for image-guided interventional therapies, announced today the appointment of Frans Venker as its new Chief Executive... ► Artikel lesen | |
07.11.24 | Mentice AB: Mentice publishes the company's interim report for the period July - September 2024 | 128 | GlobeNewswire (Europe) | A challenging summer quarter at the level of last year
SIGNIFICANT EVENTS DURING THE THIRD QUARTER 2024 (JUL - SEP)Mentice and AGIK, the Working Group of Interventional Cardiology within the German... ► Artikel lesen | |
20.09.24 | MENTICE AB: Mentice strengthens cardiology education in Germany through partnership | 6 | Cision News | ||
23.07.24 | Mentice AB: Mentice publishes the company's interim report for the period April - June 2024 | 75 | GlobeNewswire (Europe) | Net sales reaching over 100 msek and the EBITDA of 24.5 msek is the highest in the company's history
SIGNIFICANT EVENTS DURING THE SECOND QUARTER 2024 (APR - JUN)Larger repeat industry order to significant... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 58,75 | +3,25 % | BRISANTE Meldung setzt Eckert&Ziegler Aktionäre unter Zugzwang. Bitte reagieren Sie jetzt sofort! | ||
PENUMBRA | 253,60 | +0,24 % | What Analysts Are Saying About Penumbra Stock | ||
CARL ZEISS MEDITEC | 70,25 | +5,72 % | GOLDMAN SACHS stuft CARL ZEISS MEDITEC AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat Carl Zeiss Meditec von "Neutral" auf "Buy" hochgestuft und das Kursziel von 59 auf 74 Euro angehoben. Anzeichen für eine Stabilisierung... ► Artikel lesen | |
GERRESHEIMER | 80,55 | +0,44 % | Kreise: Warburg und KKR haben bei Ringen um Gerresheimer die Nase vorne | LONDON (dpa-AFX) - Beim Ringen um die mögliche Übernahme des Pharma- und Kosmetikverpackungsherstellers Gerresheimer hat offenbar ein Konsortium um die Beteiligungsgesellschaften Warburg Pincus und... ► Artikel lesen | |
FRESENIUS | 40,020 | +0,25 % | Fresenius SE & Co. KGaA-Aktie: Kurs mit wenig Bewegung (39,35 €) | Wenig Kursbewegung derzeit bei der Fresenius SE & Co. KGaA-Aktie . Der jüngste Kurs betrug 39,35 Euro. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich zur Stunde der Kurs der... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,68 | -0,19 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 58 auf 60 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Analyst Richard... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 44,200 | +0,30 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Fresenius Medical Care (FMC) von 52 auf 55 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst Richard... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 59,00 | 0,00 % | PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada | ||
ALIGNMENT HEALTHCARE | 16,075 | 0,00 % | Alignment Healthcare's CIO verkauft Aktien für 81.966 US-Dollar | ||
GENEDX | 94,62 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
ATRICURE | 33,750 | 0,00 % | AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
HYPERFINE | 1,255 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered... ► Artikel lesen | |
ACLARION | 0,870 | 0,00 % | Aclarion, Inc. - 8-K, Current Report | ||
LIFEMD | 5,660 | 0,00 % | LifeMD (NASDAQ:LFMD) Announces Earnings Results, Beats Estimates By $0.02 EPS | ||
SYNLAB | 11,600 | +1,40 % | Ikonisys SA: Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |